利巴韦林治疗急性上呼吸道感染的临床观察

目的：就利巴韦林治疗急性上呼吸道感染进行临床观察。方法：选取2010年11月到2013年11月我院所收治的90例急性上呼吸道感染患者,基于随机数字法将本组患者分为两组患者,每组45例,分别是治疗组和对照组,对照组患者给予常规治疗,治疗组在对照组的基础之上,静滴利巴韦林0.2g＋0.9%葡萄糖250mL,1次/d。结果：治疗1疗程（5d）,临床疗效治疗组优于对照组（P〈0.05）,治疗1疗程（5d）,两组体温均有改善（P〈0.05）,治疗组改善优于对照组（P〈0.05）,治疗1疗程（5d）,退热时间治疗组优于对照组（P〈0.05）,观察过程中两组均无严重不良事件。结论：利巴韦林治疗急性上呼吸道感染有效性较高,对于患者病症改善效果极其显著,值得推广。

Objective： Leigh Bhave Lin treatment of acute upper respiratory tract infection clinical observation. Methods： patients selected from 2010 November to 2013 November in our hospital treated 90 cases of acute upper respiratory tract infection, the method of random number based on the patients were divided into two groups, 45 cases in each group, the treatment group and the control group, the control group were given routine treat ment, the treatment group on the basis of the control group, ribavirin injection 0.2g ＋ 0.9% glucose 250mL, 1 /d. Results： 1 courses of treatment （5d）, the clinical curative effect in treatment group than in control group （P 〈 0.05）, 1 courses of treatment （5d）, two groups of temperature were improved （P 〈 0.05）, the treatment group was better than the control group （P 〈 0.05）, 1 courses of treatment （Sd）, the control group and the time of treatment group （P 〈 0.05）, to observe the process in two groups were no serious adverse events. Conclusion： Leigh Bhave Lin high effective treatment of acute upper respiratory tract infection, for patients with symptoms improve the effect is extremely remarkable, worthy of promotion.